I'm confused about the situation, and my confusion is compounded by the lack of understanding of the relationships between the various theaters. So excuse my dumb questions.
- What is the relationship between the Signature Theatre, where Dave Malloy is a listed as having a residency as Signature's first musical theater writer, and any other the other theaters - including ART? I assumed, perhaps incorrectly, that Malloy's agreement with Signature was a separate thing from his Moby Dick musical.
- I knew, or thought I knew, that the Moby Dick musical was being developed by the Public Theater and Berkeley Rep. (As a San Francisco Bay Area resident, I was hoping it would premiere here.) But after some delays in announcing a full season, Moby Dick wasn't on the Berkeley Rep's 2019-20 season. And it's not on the Public Theater's 2019-20 season. That seemed unusual to me. I have a hard time believing either theater would reject Malloy's Moby Dick musical. because while Great Comet may have been a financial failure on Broadway, it was a much-praised musical that raised Malloy's profile. (Octet was an easy sellout, albeit in a small theater, and he raised enough money for a cast recording in a day.)And Rachel Chavkin just won a Tony. The concert this weekend seems to have stirred a lot of attention.
- So my assumption was that something else happened instead, and that Chavkin and/or Malloy preferred to go to ART (where they have experience from Great Comet). That could be totally wrong. I don't know what role, if any, the Berkeley Rep or Public Theater have with the Moby Dick musical at this point. Any idea?
- While I'm very interested in this show, it does not seem like a Broadway musical. But the timing of the ACT run makes me think it could premiere somewhere in New York City sometime in the spring (or possibly next fall). It's clearly not headed to the Berkeley Rep or the Public Theater this season. I suppose it could the next season, or it could go somewhere else entirely as Malloy and Chavkin rework and revise it. That wouldn't surprise me, given their histories together and separately, but I probably have no clue."
Don't feel like the questions are dumb, all are totally reasonable confusions!
-There is no relationship between Signature and any other regional theater, and there is no development connection between Moby-Dick and Signature. I don't know why Dave didn't try to get the show done there after he was brought into Residency and Berkeley Rep fell through, but I would guess that: 1. Signature is too concerned about the expenses of such a large show, especially having never done a musical there before Octet, and 2. Because the show was already being developed by other theaters, it would not qualify as a Residency show since he isn't writing it in-house at Signature.
-I totally get the confusion about it not running at Berkeley Rep and/or the Public. I also grew up in the Bay Area, so I have friends who helped develop it at Berkeley Rep in its early workshops and it was made very clear to me that the show would premiere there before moving to NYC. But I was talking with Dave sometime last year and he mentioned to me that the regional theater that was supposed to premiere it fell through (presumably Berkeley Rep), but he couldn't mention any specific theaters by name to me because of legal reasons. So that's the extent of what I know about the situation, and going back to the original post this is also the reason Octet was created in the 1st year of his Residency at Signature.
-So it's not a matter of the creative team preferring to go to ART (though they have a great relationship with the company after Comet obviously). It's that wherever they were going to run the show before ART fell through, and I have no idea what the reasons would be. I assume it's financial reasons and the theaters not being able to budget it (the show is going to be 5 (?) hours long and that's an insane amount of overtime pay for everyone, particularly musicians). It could also be a matter of timing and season scheduling not working out. But those are both speculations, I wish I knew more specifics. I don't know if the theaters will have any sort of role going forward. I assume not Berkeley Rep anymore, but maybe The Public still?
-The show is definitely not heading to Broadway. I think it's safe to make the assumption that, at least for the next 5-10 years, none of Malloy's shows will go to Broadway. He has too much of a grudge against the commercialism of Broadway after Comet and he's very adamant about not taking his shows to Broadway. Also his shows are far too experimental to survive in any sort of commercial setting. So he'll live in Off-Broadway houses, and maybe he'll keep recreating commercial off-broadway ventures like the Kazino for Comet so that his shows can have open runs. I mean, he just performed Moby-Dick in the Natural History Museum, so I don't think creative performance opportunities are out of question for him.